Immunotherapy, gene editing advances extend to Type 1 Diabetes – Medical Xpress
|
Immunotherapy, gene editing advances extend to Type 1 Diabetes
Medical Xpress Dr. Jane Buckner of the Benaroya Research Institute at Virginia Mason and Dr. David Rawlings at Seattle Children’s Research Institute are leading research to develop an immunotherapy for type 1 diabetes. Credit: Seattle Children’s. Advances in … |
Columbus Business First |
Nationwide Children’s gene therapy spinout raises $2.5M to test muscular dystrophy treatment
Columbus Business First CEO Michael Triplett and COO Bruce Halpryn are based in New Albany, and all of the contract research it sponsors takes place at Children’s. “The clinical impact will be transformative. I think it’s a matter of when, not if,” Triplett said. “It will … |